<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00705614</url>
  </required_header>
  <id_info>
    <org_study_id>P03164</org_study_id>
    <nct_id>NCT00705614</nct_id>
  </id_info>
  <brief_title>Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)</brief_title>
  <acronym>ENCORE</acronym>
  <official_title>Crohn's Disease European Registry. A Prospective, Observational, Postmarketing Safety Surveillance Registry of Patients Treated With Remicade® or Standard Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, observational, parallel-group, postmarketing safety surveillance registry in
      participants treated with Remicade or standard therapy for active or fistulizing Crohn's
      disease (CD). The follow-up period is up to 5 years. The participants in the standard therapy
      group may switch over to Remicade any time during the follow-up period
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2003</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Serious Infections</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participants experiencing serious infections was evaluated. Serious infections included, but were not limited to, tuberculosis, opportunistic infections (such as Pneumocystis carinii [PCP] pneumonia, listeriosis, atypical mycobacteria, and histoplasmosis), salmonellosis,and serious viral infections.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Infusion-Related Reactions/Hypersensitivity</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participants with infusion-related reactions and/or hypersensitivity was evaluated. An infuson-related reaction/hypersensitivity was defined as as an acute reaction, including anaphylactic shock that occurs after the onset of the infusion or within the 1- to 2-hour observation period following the end of the infusion. Delayed hypersensitivity reactions (myalgia and/or arthralgia with fever and rash within 14 days of the infusion) were included.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participant Fatalities</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participant fatalities was evaluated throughout the study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With New or Worsening Congestive Heart Failure</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participants with new or worsening congestive heart failure was evaluated throughout the study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Demyelinating Neurological Disorders</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participants with demyelinating neurological disorders was evaluated. Demyelinating neurological disorders were defined as multiple sclerosis, optic neuritis, peripheral syndromes such as peripheral neuropathy, mononeuropathy multipex, cranial neuropathies, Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, and transverse myelitis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Hematologic Conditions</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participants wtih hematologic conditions was evaluated. A hematologic condition was defined as thrombocytopenia, neutropenia, pancytopenia, granulocytopenia, leukopenia, or aplastic anemia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Lymphoproliferative Disorders/Malignancies</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participants wtih lymphoproliferative disorders and/or malignancies was evaluated. A lymphoproliferative disorder and /or malignancy included, but was not limited to, lymphoma, gastrointestinal cancer, skin cancer (including basocellular and squamous carcinoma, melanoma) and in situ cervical carcinoma.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participant Assessment of Overall Health Status By Study Visit</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The participant assessment of overall health status was evaluated at baseline and each study visit. The overall health status questionnaire asked participants to rate their current health status over the prior 24 hours as 1=best possible, 2=much better than average, 3=better than average, 4=average, 5=worse than average, 6=much worse than average, or 7=worst possible. Scores ranged from 1 to 7 with lower scores indicating better health status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Harvey-Bradshaw Index of Crohn's Disease Activity By Study Visit</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The Harvey-Bradshaw Index of Crohn's Disease Acitivity was evaluated at each study visit. The Harvey-Bradshaw Index evaluates participants' general health in the day prior in the domains of well being, abdominal pain, number of liquid stools per day, and abdominal mass and complications and was evaluated on the day of the study visit. The score is derived from a 0-4 score for general well being, 0-3 for abdmonial pain, raw score for number of liquid stools per day, 0-3 for abdominal mass, and raw score for complications. The total score is from 0 to infinity, with lower scores indicating better outcomes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Work/Daily Activity Status Score By Study Visit</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The participant work/daily activity status score was evaluated at each study visit. The work/daily activity questionnaire asked participants to rate their level of daily functioning on a scale of 1 to 10 with a lower score indicating less of an impact of Crohn's disease on work or daily life functioning.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With a Draining Fistula By Study Visit</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participants with a draining fistula was evaluated at each study visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participant Hospital Stays for Crohn's Disease in the Prior 6 Months</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participant hospital stays for Crohn's Disease in the prior 6 months was evaluated at each study visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Participant Hospital Stays for Crohn's Disease in the Prior 6 Months</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The duration of hospital stays for Crohn's Disease in the prior 6 months was evaluated at each study visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participant Surgical Procedures for Crohn's Disease in the Prior 6 Months</measure>
    <time_frame>Up to 5 Years</time_frame>
    <description>The number of participants undergoing surgical procedures for Crohn's Disease in the prior 6 months was evaluated at each study visit.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">2662</enrollment>
  <condition>Crohn's Disease</condition>
  <arm_group>
    <arm_group_label>Remicade Group</arm_group_label>
    <description>Particpiants with no prior exposure to Remicade, who at the time of enrollment are scheduled to receive Remicade within 30 days of the Baseline Visit. Participants who start on Remicade will constitute the Remicade Group, regardless of whether they continue with Remicade or switch to another treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Therapy Group</arm_group_label>
    <description>Participants who are being treated with standard therapy and are not adequately maintained and will be offered an alternative treatment that does not include Remicade. Standard therapy participants must not have previously received Remicade.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Switched to Remicade Group</arm_group_label>
    <description>Participants who started in the Standard Therapy Group but switched over to Remicade sometime during the follow-up period. Participants who switch to Remicade are evaluated in the Standard Therapy group until the time of the switch and are evaluated in the Switched to Remicade group thereafter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Remicade</intervention_name>
    <description>The treating physician will determine the treatment regimen and dose of Remicade.</description>
    <arm_group_label>Remicade Group</arm_group_label>
    <arm_group_label>Switched to Remicade Group</arm_group_label>
    <other_name>Infliximab</other_name>
    <other_name>SCH 215596</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult subjects, ages 18 years and older, with a diagnosis of active or fistulizing CD with
        no previous exposure to Remicade will be eligible to enroll into the registry.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years of age, of either sex, and of any race.

          -  Must have active or fistulizing CD and must have experienced at least 1 of the
             following:

               -  failed a tapering regimen of corticosteroids and will be initiating
                  immunosuppressive therapy

               -  required corticosteroid treatments for the previous 6 months and will be
                  initiating immunosuppressive therapy

               -  luminal or fistulizing CD, which, in the treating physician's judgment, qualifies
                  for initiation of Remicade.

          -  Willing to give written informed consent and must be able to adhere to the procedural
             requirements of the registry.

          -  Must be evaluated for active and inactive (latent) tuberculosis (TB) at the Baseline
             Visit. TB evaluation will consist of TB history questions (eg, medical history,
             possible previous contact with TB, TB vaccination history). TB evaluation and TB
             screening (eg, skin test, chest x-ray) are required when a subject starts treatment
             with Remicade. In these cases, subjects must be screened for TB within 3 months prior
             to initiating Remicade treatment.

        Exclusion Criteria:

          -  Female who is pregnant or nursing.

          -  Treated with Remicade prior to Baseline.

          -  Previously treated with other tumor necrosis factor (TNF)-active agents and other
             investigational drugs for CD prior to Baseline.

          -  Active or untreated latent TB or other severe infections such as sepsis, abscesses, or
             opportunistic infections.

          -  Moderate or severe heart failure (New York Heart Association [NYHA] Class III:
             subjects with marked limitation of activity; they are comfortable only at rest/Class
             IV: subjects who should be at complete rest, confined to bed or chair; any physical
             activity brings on discomfort and symptoms occur at rest).

          -  Have lymphoproliferative disorders (eg, lymphoma) or malignancies.

          -  In a situation or have any condition that, in the opinion of the treating physician,
             may interfere with their optimal participation in the registry.

          -  Are participating in any other clinical trials (excluding registries).

        In addition, subjects will be excluded from treatment with Remicade if any of the criteria
        listed below are met:

          -  Females of childbearing potential unwilling to use a medically accepted method of
             birth control during treatment with Remicade and to continue its use for at least 6
             months after the last Remicade treatment.

          -  History of hypersensitivity to murine proteins or to any excipients of Remicade
             formulation (sucrose, polysorbate 80, monobasic sodium phosphate, and dibasic sodium
             phosphate).

          -  Other conditions that are contraindicated in the Remicade Summary of Product
             Characteristics (SPC).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>D'Haens G, Reinisch W, Colombel JF, Panes J, Ghosh S, Prantera C, Lindgren S, Hommes DW, Huang Z, Boice J, Huyck S, Cornillie F; ENCORE investigators. Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy. J Crohns Colitis. 2017 Jun 1;11(6):680-689. doi: 10.1093/ecco-jcc/jjw221.</citation>
    <PMID>28025307</PMID>
  </results_reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2008</study_first_submitted>
  <study_first_submitted_qc>June 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2008</study_first_posted>
  <results_first_submitted>February 25, 2014</results_first_submitted>
  <results_first_submitted_qc>August 11, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 26, 2014</results_first_posted>
  <last_update_submitted>February 17, 2017</last_update_submitted>
  <last_update_submitted_qc>February 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infliximab</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The Standard Therapy group includes both those who stayed on Standard Therapy and those who switched to Remicade after starting on Standard Therapy. Two hundred ninety-eight of the 1121 subjects enrolled in the Standard Therapy Group switched to Remicade during follow-up.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Remicade</title>
          <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit. The treating physician will determine the treatment regimen and dose of Remicade.</description>
        </group>
        <group group_id="P2">
          <title>Standard Therapy Group</title>
          <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.
Some participants who start in the Standard Therapy Group switched over to Remicade sometime during the follow-up period. Participants who switched to Remicade were evaluated in the Standard Therapy group until the time of the switch and were evaluated in the Switched to Remicade group thereafter.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Initial Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1541"/>
                <participants group_id="P2" count="1121"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1023"/>
                <participants group_id="P2" count="800"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="518"/>
                <participants group_id="P2" count="321"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="310"/>
                <participants group_id="P2" count="191"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="114"/>
                <participants group_id="P2" count="71"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Administrative Reason</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Status completion unknown</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Switch to Remicade</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="298"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="249"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Administrative Reason</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>298 of the 1121 participants enrolled in the Standard Therapy Group switched to Remicade during follow-up. They are included in both the Standard Therapy and Switched to Remicade treatment groups, but baseline measures (obtained at the time of their switch to Remicade) are shown as separate rows in the Baseline Measures table.</population>
      <group_list>
        <group group_id="B1">
          <title>Remicade</title>
          <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit. The treating physician will determine the treatment regimen and dose of Remicade.</description>
        </group>
        <group group_id="B2">
          <title>Standard Therapy Group</title>
          <description>The Standard Therapy group includes both those who stayed on Standard Therapy and those who switched to Remicade after starting on Standard Therapy. Two hundred ninety-eight of the 1121 subjects enrolled in the Standard Therapy Group switched to Remicade during follow-up.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1541"/>
            <count group_id="B2" value="1121"/>
            <count group_id="B3" value="2662"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>All Participants</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.1" spread="12.90"/>
                    <measurement group_id="B2" value="37.5" spread="12.86"/>
                    <measurement group_id="B3" value="36.7" spread="12.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Switched to Remicade</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Not available (N/A) because there are no participants in this group.</measurement>
                    <measurement group_id="B2" value="36.7" spread="12.3"/>
                    <measurement group_id="B3" value="36.7" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female (All Participants)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="935"/>
                    <measurement group_id="B2" value="677"/>
                    <measurement group_id="B3" value="1612"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male (All Participants)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="606"/>
                    <measurement group_id="B2" value="444"/>
                    <measurement group_id="B3" value="1050"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female (Switched to Remicade)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Not available (N/A) because there are no participants in this group.</measurement>
                    <measurement group_id="B2" value="191"/>
                    <measurement group_id="B3" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male (Switched to Remicade)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Not available (N/A) because there are no participants in this group.</measurement>
                    <measurement group_id="B2" value="107"/>
                    <measurement group_id="B3" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Serious Infections</title>
        <description>The number of participants experiencing serious infections was evaluated. Serious infections included, but were not limited to, tuberculosis, opportunistic infections (such as Pneumocystis carinii [PCP] pneumonia, listeriosis, atypical mycobacteria, and histoplasmosis), salmonellosis,and serious viral infections.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Serious Infections</title>
          <description>The number of participants experiencing serious infections was evaluated. Serious infections included, but were not limited to, tuberculosis, opportunistic infections (such as Pneumocystis carinii [PCP] pneumonia, listeriosis, atypical mycobacteria, and histoplasmosis), salmonellosis,and serious viral infections.</description>
          <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="132"/>
                    <measurement group_id="O2" value="47"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Infusion-Related Reactions/Hypersensitivity</title>
        <description>The number of participants with infusion-related reactions and/or hypersensitivity was evaluated. An infuson-related reaction/hypersensitivity was defined as as an acute reaction, including anaphylactic shock that occurs after the onset of the infusion or within the 1- to 2-hour observation period following the end of the infusion. Delayed hypersensitivity reactions (myalgia and/or arthralgia with fever and rash within 14 days of the infusion) were included.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Infusion-Related Reactions/Hypersensitivity</title>
          <description>The number of participants with infusion-related reactions and/or hypersensitivity was evaluated. An infuson-related reaction/hypersensitivity was defined as as an acute reaction, including anaphylactic shock that occurs after the onset of the infusion or within the 1- to 2-hour observation period following the end of the infusion. Delayed hypersensitivity reactions (myalgia and/or arthralgia with fever and rash within 14 days of the infusion) were included.</description>
          <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participant Fatalities</title>
        <description>The number of participant fatalities was evaluated throughout the study.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participant Fatalities</title>
          <description>The number of participant fatalities was evaluated throughout the study.</description>
          <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With New or Worsening Congestive Heart Failure</title>
        <description>The number of participants with new or worsening congestive heart failure was evaluated throughout the study.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With New or Worsening Congestive Heart Failure</title>
          <description>The number of participants with new or worsening congestive heart failure was evaluated throughout the study.</description>
          <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Demyelinating Neurological Disorders</title>
        <description>The number of participants with demyelinating neurological disorders was evaluated. Demyelinating neurological disorders were defined as multiple sclerosis, optic neuritis, peripheral syndromes such as peripheral neuropathy, mononeuropathy multipex, cranial neuropathies, Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, and transverse myelitis.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Demyelinating Neurological Disorders</title>
          <description>The number of participants with demyelinating neurological disorders was evaluated. Demyelinating neurological disorders were defined as multiple sclerosis, optic neuritis, peripheral syndromes such as peripheral neuropathy, mononeuropathy multipex, cranial neuropathies, Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, and transverse myelitis.</description>
          <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Hematologic Conditions</title>
        <description>The number of participants wtih hematologic conditions was evaluated. A hematologic condition was defined as thrombocytopenia, neutropenia, pancytopenia, granulocytopenia, leukopenia, or aplastic anemia.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Hematologic Conditions</title>
          <description>The number of participants wtih hematologic conditions was evaluated. A hematologic condition was defined as thrombocytopenia, neutropenia, pancytopenia, granulocytopenia, leukopenia, or aplastic anemia.</description>
          <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Lymphoproliferative Disorders/Malignancies</title>
        <description>The number of participants wtih lymphoproliferative disorders and/or malignancies was evaluated. A lymphoproliferative disorder and /or malignancy included, but was not limited to, lymphoma, gastrointestinal cancer, skin cancer (including basocellular and squamous carcinoma, melanoma) and in situ cervical carcinoma.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Lymphoproliferative Disorders/Malignancies</title>
          <description>The number of participants wtih lymphoproliferative disorders and/or malignancies was evaluated. A lymphoproliferative disorder and /or malignancy included, but was not limited to, lymphoma, gastrointestinal cancer, skin cancer (including basocellular and squamous carcinoma, melanoma) and in situ cervical carcinoma.</description>
          <population>The population consisted of all enrolled participants. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participant Assessment of Overall Health Status By Study Visit</title>
        <description>The participant assessment of overall health status was evaluated at baseline and each study visit. The overall health status questionnaire asked participants to rate their current health status over the prior 24 hours as 1=best possible, 2=much better than average, 3=better than average, 4=average, 5=worse than average, 6=much worse than average, or 7=worst possible. Scores ranged from 1 to 7 with lower scores indicating better health status.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants with a Participant Assessment of Overall Health Index score at baseline and each time point. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Participant Assessment of Overall Health Status By Study Visit</title>
          <description>The participant assessment of overall health status was evaluated at baseline and each study visit. The overall health status questionnaire asked participants to rate their current health status over the prior 24 hours as 1=best possible, 2=much better than average, 3=better than average, 4=average, 5=worse than average, 6=much worse than average, or 7=worst possible. Scores ranged from 1 to 7 with lower scores indicating better health status.</description>
          <population>The population consisted of all enrolled participants with a Participant Assessment of Overall Health Index score at baseline and each time point. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Score on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visit 1 (Baseline; n=1526, 1116, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="1.33"/>
                    <measurement group_id="O2" value="3.9" spread="1.38"/>
                    <measurement group_id="O3" value="NA">Due to the study design, participants would not have switched to Remicade at the Baseline visit.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2 (n=1344, 903, 95)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="1.44"/>
                    <measurement group_id="O2" value="3.3" spread="1.44"/>
                    <measurement group_id="O3" value="3.9" spread="1.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3 (n=1280, 809, 146)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.41"/>
                    <measurement group_id="O2" value="3.1" spread="1.40"/>
                    <measurement group_id="O3" value="3.6" spread="1.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 4 (n=1217, 755, 162)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="1.43"/>
                    <measurement group_id="O2" value="3.0" spread="1.38"/>
                    <measurement group_id="O3" value="3.5" spread="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 5 (n=1160, 704, 184)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.44"/>
                    <measurement group_id="O2" value="3.1" spread="1.42"/>
                    <measurement group_id="O3" value="3.2" spread="1.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 6 (n=1110, 649, 202)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.43"/>
                    <measurement group_id="O2" value="3.0" spread="1.41"/>
                    <measurement group_id="O3" value="3.4" spread="1.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 7 (n=1046, 606, 212)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.47"/>
                    <measurement group_id="O2" value="3.0" spread="1.41"/>
                    <measurement group_id="O3" value="3.3" spread="1.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 8 (n=1044, 573, 221)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.46"/>
                    <measurement group_id="O2" value="3.0" spread="1.44"/>
                    <measurement group_id="O3" value="3.2" spread="1.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 9 (n=999, 544, 223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="1.45"/>
                    <measurement group_id="O2" value="2.9" spread="1.41"/>
                    <measurement group_id="O3" value="3.2" spread="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 10 (n=963, 520, 227)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="1.42"/>
                    <measurement group_id="O2" value="2.8" spread="1.44"/>
                    <measurement group_id="O3" value="3.1" spread="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 11 (n=956, 527, 235)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="1.41"/>
                    <measurement group_id="O2" value="2.8" spread="1.43"/>
                    <measurement group_id="O3" value="3.1" spread="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Harvey-Bradshaw Index of Crohn's Disease Activity By Study Visit</title>
        <description>The Harvey-Bradshaw Index of Crohn's Disease Acitivity was evaluated at each study visit. The Harvey-Bradshaw Index evaluates participants' general health in the day prior in the domains of well being, abdominal pain, number of liquid stools per day, and abdominal mass and complications and was evaluated on the day of the study visit. The score is derived from a 0-4 score for general well being, 0-3 for abdmonial pain, raw score for number of liquid stools per day, 0-3 for abdominal mass, and raw score for complications. The total score is from 0 to infinity, with lower scores indicating better outcomes.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants with a Harvey-Bradshaw Index of Crohn's Disease score at baseline and each time point. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>The Harvey-Bradshaw Index of Crohn's Disease Activity By Study Visit</title>
          <description>The Harvey-Bradshaw Index of Crohn's Disease Acitivity was evaluated at each study visit. The Harvey-Bradshaw Index evaluates participants' general health in the day prior in the domains of well being, abdominal pain, number of liquid stools per day, and abdominal mass and complications and was evaluated on the day of the study visit. The score is derived from a 0-4 score for general well being, 0-3 for abdmonial pain, raw score for number of liquid stools per day, 0-3 for abdominal mass, and raw score for complications. The total score is from 0 to infinity, with lower scores indicating better outcomes.</description>
          <population>The population consisted of all enrolled participants with a Harvey-Bradshaw Index of Crohn's Disease score at baseline and each time point. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Score on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visit 1 (Baseline; n=1505, 1106, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2" spread="5.36"/>
                    <measurement group_id="O2" value="6.2" spread="4.94"/>
                    <measurement group_id="O3" value="NA">Due to the study design, participants would not have switched to Remicade at the Baseline visit.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2 (n=1320, 876, 91)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="4.13"/>
                    <measurement group_id="O2" value="3.8" spread="3.84"/>
                    <measurement group_id="O3" value="6.0" spread="5.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3 (n=1250, 785, 143)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="3.87"/>
                    <measurement group_id="O2" value="3.5" spread="3.64"/>
                    <measurement group_id="O3" value="4.4" spread="4.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 4 (n=1196, 742, 159)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="4.01"/>
                    <measurement group_id="O2" value="3.2" spread="3.56"/>
                    <measurement group_id="O3" value="4.8" spread="4.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 5 (n=1127, 692, 181)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="3.95"/>
                    <measurement group_id="O2" value="3.4" spread="3.51"/>
                    <measurement group_id="O3" value="4.9" spread="5.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 6 (n=1070, 647, 199)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="4.00"/>
                    <measurement group_id="O2" value="3.1" spread="3.39"/>
                    <measurement group_id="O3" value="4.5" spread="4.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 7 (n=1023, 592, 209)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="4.00"/>
                    <measurement group_id="O2" value="3.0" spread="3.36"/>
                    <measurement group_id="O3" value="4.1" spread="4.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 8 (n=1015, 562, 224)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="3.97"/>
                    <measurement group_id="O2" value="3.2" spread="3.63"/>
                    <measurement group_id="O3" value="4.1" spread="4.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 9 (n=953, 546, 219)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="4.50"/>
                    <measurement group_id="O2" value="2.9" spread="2.90"/>
                    <measurement group_id="O3" value="4.4" spread="5.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 10 (n=936, 526, 225)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="4.23"/>
                    <measurement group_id="O2" value="2.7" spread="3.38"/>
                    <measurement group_id="O3" value="4.3" spread="4.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 11 (n=918, 525, 238)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="3.93"/>
                    <measurement group_id="O2" value="2.7" spread="3.44"/>
                    <measurement group_id="O3" value="4.2" spread="4.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Work/Daily Activity Status Score By Study Visit</title>
        <description>The participant work/daily activity status score was evaluated at each study visit. The work/daily activity questionnaire asked participants to rate their level of daily functioning on a scale of 1 to 10 with a lower score indicating less of an impact of Crohn's disease on work or daily life functioning.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all participants with a work/daily activity status score at baseline and each study visit. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Work/Daily Activity Status Score By Study Visit</title>
          <description>The participant work/daily activity status score was evaluated at each study visit. The work/daily activity questionnaire asked participants to rate their level of daily functioning on a scale of 1 to 10 with a lower score indicating less of an impact of Crohn's disease on work or daily life functioning.</description>
          <population>The population consisted of all participants with a work/daily activity status score at baseline and each study visit. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Score on a Scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visit 1 (Baseline; n=1496, 1108, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="2.61"/>
                    <measurement group_id="O2" value="4.9" spread="2.83"/>
                    <measurement group_id="O3" value="NA">Due to the study design, participants would not have switched to Remicade at the Baseline visit.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2 (n=1316, 895, 94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="2.86"/>
                    <measurement group_id="O2" value="3.7" spread="2.79"/>
                    <measurement group_id="O3" value="5.5" spread="2.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3 (n=1235, 797, 143)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="2.76"/>
                    <measurement group_id="O2" value="3.2" spread="2.77"/>
                    <measurement group_id="O3" value="4.8" spread="2.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 4 (n=1192, 738, 159)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="2.79"/>
                    <measurement group_id="O2" value="2.9" spread="2.60"/>
                    <measurement group_id="O3" value="4.3" spread="2.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 5 (n=1128, 694, 179)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="2.76"/>
                    <measurement group_id="O2" value="3.0" spread="2.63"/>
                    <measurement group_id="O3" value="4.0" spread="2.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 6 (n=1077, 638, 201)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="2.75"/>
                    <measurement group_id="O2" value="2.7" spread="2.56"/>
                    <measurement group_id="O3" value="3.9" spread="2.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 7 (n=1030, 601, 207)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="2.70"/>
                    <measurement group_id="O2" value="2.8" spread="2.62"/>
                    <measurement group_id="O3" value="3.6" spread="2.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 8 (n=1025, 571, 221)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="2.75"/>
                    <measurement group_id="O2" value="2.7" spread="2.59"/>
                    <measurement group_id="O3" value="3.5" spread="2.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 9 (n=982, 542, 222)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="2.75"/>
                    <measurement group_id="O2" value="2.6" spread="2.46"/>
                    <measurement group_id="O3" value="3.5" spread="2.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 10 (n=934, 514, 225)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="2.66"/>
                    <measurement group_id="O2" value="2.4" spread="2.53"/>
                    <measurement group_id="O3" value="3.6" spread="2.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 11 (n=925, 521, 235)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="2.67"/>
                    <measurement group_id="O2" value="2.4" spread="2.44"/>
                    <measurement group_id="O3" value="3.6" spread="2.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With a Draining Fistula By Study Visit</title>
        <description>The number of participants with a draining fistula was evaluated at each study visit.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants with fistula status data. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Draining Fistula By Study Visit</title>
          <description>The number of participants with a draining fistula was evaluated at each study visit.</description>
          <population>The population consisted of all enrolled participants with fistula status data. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visit 1 (Baseline; n=1541, 1120, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="349"/>
                    <measurement group_id="O2" value="96"/>
                    <measurement group_id="O3" value="NA">Due to the study design, participants would not have switched to Remicade at the Baseline visit.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2 (n=1420, 920, 100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="211"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3 (n=1334, 827, 152)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="170"/>
                    <measurement group_id="O2" value="41"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 4 (n=1285, 779, 168)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 5 (n=1221, 714, 188)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="125"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 6 (n=1169, 666, 208)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 7 (n=1110, 615, 219)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 8 (n=1097, 588, 233)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 9 (n=1046, 562, 229)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 10 (n=1030, 535, 235)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 11 (n=1006, 541, 248)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participant Hospital Stays for Crohn's Disease in the Prior 6 Months</title>
        <description>The number of participant hospital stays for Crohn's Disease in the prior 6 months was evaluated at each study visit.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants with hospital stay data. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participant Hospital Stays for Crohn's Disease in the Prior 6 Months</title>
          <description>The number of participant hospital stays for Crohn's Disease in the prior 6 months was evaluated at each study visit.</description>
          <population>The population consisted of all enrolled participants with hospital stay data. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Hospital Stays</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visit 1 (Baseline; n=1539, 1121, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="1.25"/>
                    <measurement group_id="O2" value="0.5" spread="0.81"/>
                    <measurement group_id="O3" value="NA">Due to the study design, participants would not have switched to Remicade at the Baseline visit.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2 (n=1418, 920, 100)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.87"/>
                    <measurement group_id="O2" value="0.2" spread="0.50"/>
                    <measurement group_id="O3" value="0.5" spread="0.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3 (n=1334, 827, 152)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.92"/>
                    <measurement group_id="O2" value="0.1" spread="0.38"/>
                    <measurement group_id="O3" value="0.4" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 4 (n=1285, 779, 168)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.56"/>
                    <measurement group_id="O2" value="0.2" spread="3.08"/>
                    <measurement group_id="O3" value="0.2" spread="0.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 5 (n=1221, 714, 188)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.54"/>
                    <measurement group_id="O2" value="0.1" spread="0.28"/>
                    <measurement group_id="O3" value="0.3" spread="0.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 6 (n=1170, 665, 208)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.66"/>
                    <measurement group_id="O2" value="0.1" spread="0.33"/>
                    <measurement group_id="O3" value="0.1" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 7 (n=1111, 615, 219)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.40"/>
                    <measurement group_id="O2" value="0.1" spread="0.43"/>
                    <measurement group_id="O3" value="0.2" spread="0.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 8 (n=1099, 589, 233)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.76"/>
                    <measurement group_id="O2" value="0.1" spread="0.42"/>
                    <measurement group_id="O3" value="0.1" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 9 (n=1046, 562, 229)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.68"/>
                    <measurement group_id="O2" value="0.1" spread="0.50"/>
                    <measurement group_id="O3" value="0.1" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 10 (n=1031, 535, 235)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.46"/>
                    <measurement group_id="O2" value="0.1" spread="0.42"/>
                    <measurement group_id="O3" value="0.1" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 11 (n=1006, 541, 248)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.35"/>
                    <measurement group_id="O2" value="0.1" spread="2.59"/>
                    <measurement group_id="O3" value="0.1" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Participant Hospital Stays for Crohn's Disease in the Prior 6 Months</title>
        <description>The duration of hospital stays for Crohn's Disease in the prior 6 months was evaluated at each study visit.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants with hospital stay duration data. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Participant Hospital Stays for Crohn's Disease in the Prior 6 Months</title>
          <description>The duration of hospital stays for Crohn's Disease in the prior 6 months was evaluated at each study visit.</description>
          <population>The population consisted of all enrolled participants with hospital stay duration data. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visit 1 (Baseline; n=657,418 ,0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.2" spread="13.73"/>
                    <measurement group_id="O2" value="10.8" spread="10.93"/>
                    <measurement group_id="O3" value="NA">Due to the study design, participants would not have switched to Remicade at the Baseline visit.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2 (n=304,126, 33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.4" spread="17.81"/>
                    <measurement group_id="O2" value="12.0" spread="14.26"/>
                    <measurement group_id="O3" value="13.0" spread="12.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3 (n=216, 58, 35)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.2" spread="16.83"/>
                    <measurement group_id="O2" value="9.4" spread="7.49"/>
                    <measurement group_id="O3" value="13.5" spread="13.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 4 (n=151, 60, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.6" spread="15.23"/>
                    <measurement group_id="O2" value="8.5" spread="11.87"/>
                    <measurement group_id="O3" value="9.1" spread="10.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 5 (n=105, 35, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.7" spread="13.02"/>
                    <measurement group_id="O2" value="9.8" spread="9.49"/>
                    <measurement group_id="O3" value="7.1" spread="6.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 6 (n=107, 49, 19)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.8" spread="17.33"/>
                    <measurement group_id="O2" value="13.7" spread="27.34"/>
                    <measurement group_id="O3" value="18.3" spread="17.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 7 (n=109, 45, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.6" spread="14.41"/>
                    <measurement group_id="O2" value="10.2" spread="10.63"/>
                    <measurement group_id="O3" value="10.0" spread="11.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 8 (n=98, 29, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" spread="9.04"/>
                    <measurement group_id="O2" value="16.3" spread="15.52"/>
                    <measurement group_id="O3" value="14.7" spread="17.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 9 (n=80, 38, 17)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.4" spread="14.44"/>
                    <measurement group_id="O2" value="6.9" spread="5.77"/>
                    <measurement group_id="O3" value="10.7" spread="17.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 10 (n=85, 29, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1" spread="12.02"/>
                    <measurement group_id="O2" value="8.0" spread="5.41"/>
                    <measurement group_id="O3" value="9.0" spread="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 11 (n=63, 19, 18)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.4" spread="13.24"/>
                    <measurement group_id="O2" value="8.7" spread="10.64"/>
                    <measurement group_id="O3" value="18.1" spread="31.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participant Surgical Procedures for Crohn's Disease in the Prior 6 Months</title>
        <description>The number of participants undergoing surgical procedures for Crohn's Disease in the prior 6 months was evaluated at each study visit.</description>
        <time_frame>Up to 5 Years</time_frame>
        <population>The population consisted of all enrolled participants with surgical procedure data. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
        <group_list>
          <group group_id="O1">
            <title>Remicade</title>
            <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
          </group>
          <group group_id="O2">
            <title>Standard Therapy</title>
            <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
          </group>
          <group group_id="O3">
            <title>Switched to Remicade</title>
            <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participant Surgical Procedures for Crohn's Disease in the Prior 6 Months</title>
          <description>The number of participants undergoing surgical procedures for Crohn's Disease in the prior 6 months was evaluated at each study visit.</description>
          <population>The population consisted of all enrolled participants with surgical procedure data. The Standard Therapy group was assessed only as long as they were on Standard Therapy without Remicade and the Switched group was assessed starting at the time of the switch to Remicade.</population>
          <units>Surgical Procedures</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1541"/>
                <count group_id="O2" value="1121"/>
                <count group_id="O3" value="298"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visit 1 (Basline; n=660, 419, 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="171"/>
                    <measurement group_id="O2" value="81"/>
                    <measurement group_id="O3" value="NA">Due to the study design, participants would not have switched to Remicade at the Baseline visit.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2 (n=304, 126, 33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3 (n=217, 57, 36)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 4 (n=153, 60, 24)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 5 (n=106, 36, 34)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 6 (n=108, 49, 19)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 7 (n=109, 45, 25)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 8 (n=98, 29, 23)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 9 (n=82, 38, 17)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 10 (n=85, 29, 27)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 11 (n=63, 19, 18)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 5 Years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard Therapy</title>
          <description>Participants who were treated with conventional therapies and who were adequately maintained were offered an alternative treatment that did not include Remicade. These participants must not have received treatment with Remicade prior to enrollment.</description>
        </group>
        <group group_id="E2">
          <title>Remicade</title>
          <description>Participants with no prior exposure to Remicade, who at the time of enrollment, were scheduled to receive Remicade within 30 days of the enrollment visit.</description>
        </group>
        <group group_id="E3">
          <title>Switched to Remicade</title>
          <description>Participants who started in the Standard Therapy Group but switched over to Remicade during the study.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 13.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="391" subjects_at_risk="1121"/>
                <counts group_id="E2" subjects_affected="792" subjects_at_risk="1541"/>
                <counts group_id="E3" subjects_affected="136" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="1121"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAEMIA HAEMOLYTIC AUTOIMMUNE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAEMIA VITAMIN B12 DEFICIENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BONE MARROW FAILURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FEBRILE NEUTROPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HAEMOLYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HAEMOLYTIC URAEMIC SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGIC ANAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>IRON DEFICIENCY ANAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LEUKOPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LYMPHADENITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LYMPHADENOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MICROCYTIC ANAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NEUTROPENIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PANCYTOPENIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THROMBOTIC THROMBOCYTOPENIC PURPURA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THYMUS DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE CORONARY SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ACUTE MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANGINA PECTORIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CONGESTIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CARDIAC VALVE DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERICARDITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PLEUROPERICARDITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TACHYARRHYTHMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TACHYCARDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>CONGENITAL ANOMALY IN OFFSPRING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENCEPHALOCELE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HAEMANGIOMA CONGENITAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HIP DYSPLASIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PRETERNATURAL ANUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PYLORIC STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>HYPOACUSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VERTIGO</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>ADRENOCORTICAL INSUFFICIENCY ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GOITRE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYPERPARATHYROIDISM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYPOTHYROIDISM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>CATARACT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLOUR BLINDNESS ACQUIRED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UVEITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL ADHESIONS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABDOMINAL DISTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABDOMINAL HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="30" subjects_affected="29" subjects_at_risk="1121"/>
                <counts group_id="E2" events="49" subjects_affected="42" subjects_at_risk="1541"/>
                <counts group_id="E3" events="10" subjects_affected="9" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN LOWER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPPER</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ACUTE ABDOMEN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAL FISSURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAL FISTULA</sub_title>
                <counts group_id="E1" events="18" subjects_affected="11" subjects_at_risk="1121"/>
                <counts group_id="E2" events="57" subjects_affected="47" subjects_at_risk="1541"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAL SKIN TAGS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAL SPHINCTER ATONY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANOGENITAL DYSPLASIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANOVULVAR FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>APHTHOUS STOMATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ASCITES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BILE ACID MALABSORPTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLITIS</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1121"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLITIS ULCERATIVE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLONIC FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLONIC OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLONIC STENOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CROHN'S DISEASE</sub_title>
                <counts group_id="E1" events="164" subjects_affected="131" subjects_at_risk="1121"/>
                <counts group_id="E2" events="460" subjects_affected="298" subjects_at_risk="1541"/>
                <counts group_id="E3" events="67" subjects_affected="47" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1121"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="1541"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DIARRHOEA HAEMORRHAGIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DUODENAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENTERITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENTEROCOLITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENTEROCOLONIC FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENTEROCUTANEOUS FISTULA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENTEROVESICAL FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FAECAL INCONTINENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FAECALOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FLATULENCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FOOD POISONING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FREQUENT BOWEL MOVEMENTS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTRIC ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTRIC ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTRODUODENAL ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL DYSPLASIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL FISTULA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL HYPOMOTILITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL INFLAMMATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL MOTILITY DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL STENOSIS</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="1121"/>
                <counts group_id="E2" events="15" subjects_affected="9" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL TOXICITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HAEMATEMESIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HAEMORRHOIDAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HERNIAL EVENTRATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ILEAL FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ILEAL PERFORATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ILEAL STENOSIS</sub_title>
                <counts group_id="E1" events="21" subjects_affected="20" subjects_at_risk="1121"/>
                <counts group_id="E2" events="45" subjects_affected="41" subjects_at_risk="1541"/>
                <counts group_id="E3" events="10" subjects_affected="9" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ILEITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ILEUS</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="1121"/>
                <counts group_id="E2" events="19" subjects_affected="17" subjects_at_risk="1541"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INFLAMMATORY BOWEL DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL ANGINA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL FISTULA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL INFARCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="1121"/>
                <counts group_id="E2" events="44" subjects_affected="36" subjects_at_risk="1541"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL PERFORATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL POLYP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL STENOSIS</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1121"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTUSSUSCEPTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>JEJUNAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINAL ULCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINE PERFORATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINE POLYP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MALABSORPTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MECHANICAL ILEUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MELAENA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MESENTERIC OCCLUSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MESENTERIC VASCULAR INSUFFICIENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL VARICES HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PANCREATITIS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1121"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PANCREATITIS ACUTE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="4" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PEPTIC ULCER HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POUCHITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PROCTALGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PROCTITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PROCTOCOLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RECTAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RECTAL PROLAPSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RECTAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="1121"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL PERFORATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL STENOSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>STOMATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SUBILEUS</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="1121"/>
                <counts group_id="E2" events="21" subjects_affected="17" subjects_at_risk="1541"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UMBILICAL HERNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UPPER GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>ADHESION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ADVERSE DRUG REACTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ASTHENIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CARDIAC DEATH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CONDITION AGGRAVATED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DEATH NEONATAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DRUG INEFFECTIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DRUG INTOLERANCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GENERAL PHYSICAL HEALTH DETERIORATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HERNIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>IMPAIRED HEALING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INFLAMMATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LOCALISED OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MALAISE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MEDICAL DEVICE COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MULTI-ORGAN FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NECROSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NON-CARDIAC CHEST PAIN</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OEDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="1121"/>
                <counts group_id="E2" events="19" subjects_affected="16" subjects_at_risk="1541"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SEROSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SUDDEN DEATH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>AUTOIMMUNE HEPATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BILE DUCT STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BILE DUCT STONE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BILIARY COLIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLANGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLANGITIS SCLEROSING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS CHRONIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLECYSTOCHOLANGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLELITHIASIS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1121"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLESTASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLESTASIS OF PREGNANCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DRUG-INDUCED LIVER INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HEPATIC FUNCTION ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HEPATITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HEPATORENAL FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>JAUNDICE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PORTAL HYPERTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAPHYLACTIC REACTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAPHYLACTIC SHOCK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAPHYLACTOID REACTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DRUG HYPERSENSITIVITY</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYPERSENSITIVITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINE TRANSPLANT REJECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SERUM SICKNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TYPE IV HYPERSENSITIVITY REACTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL ABSCESS</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="1121"/>
                <counts group_id="E2" events="23" subjects_affected="20" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABDOMINAL SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABDOMINAL WALL ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABSCESS</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="1121"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABSCESS INTESTINAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ABSCESS SWEAT GLAND</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ACINETOBACTER BACTERAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ACUTE SINUSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ACUTE TONSILLITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>AMOEBIC DYSENTERY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAL ABSCESS</sub_title>
                <counts group_id="E1" events="21" subjects_affected="17" subjects_at_risk="1121"/>
                <counts group_id="E2" events="83" subjects_affected="61" subjects_at_risk="1541"/>
                <counts group_id="E3" events="12" subjects_affected="8" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>APPENDICITIS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ARTHRITIS INFECTIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ATYPICAL PNEUMONIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BACTERAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BACTERIAL PYELONEPHRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BACTERIAL SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BARTHOLIN'S ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BRONCHOPNEUMONIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CAMPYLOBACTER GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CAMPYLOBACTER INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHLAMYDIAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHRONIC SINUSITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHRONIC TONSILLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIUM DIFFICILE COLITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIUM DIFFICILE INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CYSTITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CYTOMEGALOVIRUS COLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CYTOMEGALOVIRUS HEPATITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CYTOMEGALOVIRUS INFECTION</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DIARRHOEA INFECTIOUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DIVERTICULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENDOCARDITIS STAPHYLOCOCCAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENTEROCOLITIS INFECTIOUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>EPSTEIN-BARR VIRUS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ERYSIPELAS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA BACTERAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FEBRILE INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1121"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS PSEUDOMONAS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS SALMONELLA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS VIRAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GENITAL ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GENITOURINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GIARDIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GROIN ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HAEMATOMA INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HEPATITIS E</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HERPES VIRUS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HERPES ZOSTER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HERPES ZOSTER OPHTHALMIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HORDEOLUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HUMAN HERPESVIRUS 6 INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INFECTIVE THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LARYNGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LISTERIOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LIVER ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LOBAR PNEUMONIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LOWER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LUNG ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LUNG INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MENINGITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MENINGITIS LISTERIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MENINGITIS STAPHYLOCOCCAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MENINGITIS VIRAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MENINGOENCEPHALITIS BACTERIAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MYCOBACTERIAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MYCOPLASMA INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NASOPHARYNGITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ORAL HERPES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OTITIS MEDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OVARIAN ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PAPILLOMA VIRAL INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PARONYCHIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PELVIC ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERINEAL ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERIRECTAL ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERITONEAL ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERITONITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERITONSILLAR ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PHARYNGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PILONIDAL CYST</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1121"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PNEUMONIA MYCOPLASMAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE WOUND INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PSEUDOMEMBRANOUS COLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PSOAS ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PULMONARY TUBERCULOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PURULENT DISCHARGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RECTAL ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RECTOVAGINAL SEPTUM ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RETROPERITONEAL ABSCESS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SALMONELLOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SALPINGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SEPSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SEPTIC SHOCK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SKIN INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>STITCH ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SUBCUTANEOUS ABSCESS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TONSILLITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TOOTH ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TOXOPLASMOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TUBERCULOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TUBERCULOSIS GASTROINTESTINAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION BACTERIAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UROSEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VAGINAL ABSCESS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VAGINAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VIRAL DIARRHOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VIRAL INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VIRAL PERICARDITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VULVAL ABSCESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>WOUND INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>ANASTOMOTIC COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANASTOMOTIC FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANASTOMOTIC LEAK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANASTOMOTIC STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANKLE FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CERVICAL VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CRANIOCEREBRAL INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>EXPOSURE DURING PREGNANCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FACIAL BONES FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FEMORAL NECK FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FEMUR FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FIBULA FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FOOT FRACTURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL ANASTOMOTIC LEAK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL STOMA COMPLICATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HEAD INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HEPATIC HAEMATOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HEPATIC RUPTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HUMERUS FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INCISIONAL HERNIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INFUSION RELATED REACTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>JAW FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LACERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LIMB INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LIMB TRAUMATIC AMPUTATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MENISCUS INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MULTIPLE FRACTURES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OVERDOSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POISONING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL COMPLICATION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL DIARRHOEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POST PROCEDURAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE FEVER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE ILEUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE WOUND COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PROCEDURAL COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PROCEDURAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PROCEDURAL SITE REACTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RADIUS FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RIB FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ROAD TRAFFIC ACCIDENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SEROMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SKULL FRACTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SPINAL FRACTURE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SPLENIC RUPTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SUBCUTANEOUS HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SUTURE RELATED COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TENDON INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TENDON RUPTURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THERMAL BURN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THORACIC VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TIBIA FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TOOTH INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TOXICITY TO VARIOUS AGENTS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UPPER LIMB FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>WOUND COMPLICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>BIOPSY LIVER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BLOOD SODIUM DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BODY TEMPERATURE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CYTOMEGALOVIRUS TEST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FALSE POSITIVE INVESTIGATION RESULT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HEPATIC ENZYME INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INVESTIGATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LIVER FUNCTION TEST ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NOROVIRUS TEST POSITIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VOLUME BLOOD DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>WEIGHT DECREASED</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>DECREASED APPETITE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="27" subjects_affected="11" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DIABETES MELLITUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ELECTROLYTE IMBALANCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FLUID RETENTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FOOD INTOLERANCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYPOCALCAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYPOGLYCAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYPOKALAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYPOPHAGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MALNUTRITION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>METABOLIC ACIDOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OBESITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OVERWEIGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VITAMIN K DEFICIENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ARTHRITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ARTHRITIS ENTEROPATHIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ARTHRITIS REACTIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BURSITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHONDROPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FIBROMYALGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FISTULA</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1121"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FISTULA DISCHARGE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FLANK PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FOOT DEFORMITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FRACTURE DELAYED UNION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC PROTRUSION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>JOINT STIFFNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LUMBAR SPINAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LUPUS-LIKE SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>METATARSALGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MONARTHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MUSCLE ATROPHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CHEST PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MYALGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OSTEONECROSIS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PATHOLOGICAL FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERIARTHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POLYARTHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RHABDOMYOLYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ROTATOR CUFF SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SLE ARTHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SPINAL OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SPONDYLITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SYNOVITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SYSTEMIC LUPUS ERYTHEMATOSUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TRISMUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL NEOPLASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ACUTE LEUKAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ACUTE MYELOID LEUKAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA GASTRIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA OF COLON</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANAL CANCER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANOGENITAL WARTS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>B-CELL LYMPHOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BASAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BENIGN NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BENIGN SOFT TISSUE NEOPLASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BENIGN UTERINE NEOPLASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BLADDER TRANSITIONAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BRAIN NEOPLASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BREAST CANCER</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CERVIX CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHRONIC MYELOID LEUKAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLON CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENDOMETRIAL CANCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL TRACT ADENOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HODGKIN'S DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LARYNGEAL CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LUNG CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LUNG NEOPLASM MALIGNANT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LYMPHOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LYMPHOPROLIFERATIVE DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MALIGNANT PERITONEAL NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MELANOCYTIC NAEVUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MENINGIOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>METASTASES TO LIVER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>METASTASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>METASTATIC LYMPHOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NON-HODGKIN'S LYMPHOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NON-SMALL CELL LUNG CANCER METASTATIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OVARIAN ADENOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OVARIAN CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PANCREATIC CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RECTAL ADENOCARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RECTAL ADENOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RECTAL CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RENAL CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SKIN CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINE ADENOCARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINE CARCINOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THYROID ADENOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THYROID NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>URETERIC CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UTERINE CANCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UTERINE LEIOMYOMA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VULVAL CANCER STAGE 0</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>CEREBRAL ARTERY THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CEREBRAL ATROPHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CEREBRAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CEREBROVASCULAR ACCIDENT</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COMPLEX REGIONAL PAIN SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>EPILEPSY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GRAND MAL CONVULSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTRACRANIAL ANEURYSM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ISCHAEMIC STROKE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LOSS OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MIGRAINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NERVE ROOT COMPRESSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NEUROLOGICAL SYMPTOM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OPTIC NEURITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PARAESTHESIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PARALYSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PYRAMIDAL TRACT SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SCIATICA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SUBARACHNOID HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SYNCOPE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TENSION HEADACHE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TRANSIENT ISCHAEMIC ATTACK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>ABORTION SPONTANEOUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BREECH PRESENTATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DELIVERY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ECTOPIC PREGNANCY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FOETAL DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FOETAL GROWTH RESTRICTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>GESTATIONAL DIABETES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NORMAL LABOUR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PLACENTAL DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POSTPARTUM HAEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PRE-ECLAMPSIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PREGNANCY</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PREMATURE BABY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PREMATURE DELIVERY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>TWIN PREGNANCY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UMBILICAL GRANULOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UTERINE CONTRACTIONS ABNORMAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>AGGRESSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ALCOHOL ABUSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ANXIETY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COMPLETED SUICIDE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="9" subjects_affected="6" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DEPRESSION SUICIDAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DYSTHYMIC DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENCOPRESIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MENTAL DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PANIC ATTACK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POST-TRAUMATIC STRESS DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SOMATISATION DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SUICIDE ATTEMPT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>CALCULUS URETERIC</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CALCULUS URINARY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYDRONEPHROSIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>IGA NEPHROPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NEPHRITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NEPHROLITHIASIS</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="1121"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PNEUMATURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POSTRENAL FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RENAL COLIC</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RENAL IMPAIRMENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RENAL MASS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>URETERIC OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>URETERIC STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>URETHRAL FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>URETHRAL STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>URINARY TRACT OBSTRUCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>BARTHOLIN'S CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BARTHOLINITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BREAST MASS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BREAST PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CERVICAL DYSPLASIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CYSTOCELE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENDOMETRIOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>EPIDIDYMITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FEMALE GENITAL TRACT FISTULA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INFERTILITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OVARIAN CYST</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OVARIAN CYST RUPTURED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>OVARIAN DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERINEAL FISTULA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UTERINE MALPOSITION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>UTERINE PROLAPSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VAGINAL FISTULA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE PULMONARY OEDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BRONCHOPNEUMOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>BRONCHOSPASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHRONIC OBSTRUCTIVE PULMONARY DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>EPISTAXIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LUNG DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LUNG INFILTRATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NASAL SEPTUM DEVIATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PLEURISY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PNEUMONIA ASPIRATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PNEUMOTHORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PULMONARY EMBOLISM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SLEEP APNOEA SYNDROME</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VOCAL CORD POLYP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE FEBRILE NEUTROPHILIC DERMATOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DERMAL CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DERMATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DERMATITIS BULLOUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DERMATITIS EXFOLIATIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DRUG ERUPTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DYSHIDROTIC ECZEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ERYTHEMA NODOSUM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HENOCH-SCHONLEIN PURPURA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HIDRADENITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>NIGHT SWEATS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PSORIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PURPURA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PUSTULAR PSORIASIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PYODERMA GANGRENOSUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>STEVENS-JOHNSON SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>URTICARIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>FAMILIAL RISK FACTOR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PREGNANCY OF PARTNER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>CAESAREAN SECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1541"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CHOLECYSTECTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLECTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLOSTOMY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>COLOSTOMY CLOSURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ENTEROSTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>FISTULA REPAIR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HAEMATOPOIETIC STEM CELL MOBILISATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HOSPITALISATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYSTERECTOMY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ILEECTOMY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ILEOSTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ILEOSTOMY CLOSURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA REPAIR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL ANASTOMOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>INTESTINAL RESECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>LIVER TRANSPLANT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MACROPHAGE ACTIVATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>MITRAL VALVE REPLACEMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>POLYPECTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL RESECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SURGERY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THYROIDECTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>AORTIC DISSECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>AORTIC OCCLUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>AORTIC STENOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ARTERIAL THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ARTERIOSCLEROSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CIRCULATORY COLLAPSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>DEEP VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HAEMATOMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>HYPOTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ISCHAEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>ORTHOSTATIC HYPOTENSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERIAL OCCLUSIVE DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ISCHAEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>SUBCLAVIAN VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THROMBOPHLEBITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>THROMBOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1541"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>VENOUS THROMBOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1121"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1541"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 13.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="173" subjects_at_risk="1121"/>
                <counts group_id="E2" subjects_affected="441" subjects_at_risk="1541"/>
                <counts group_id="E3" subjects_affected="51" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="45" subjects_affected="41" subjects_at_risk="1121"/>
                <counts group_id="E2" events="124" subjects_affected="100" subjects_at_risk="1541"/>
                <counts group_id="E3" events="18" subjects_affected="15" subjects_at_risk="298"/>
              </event>
              <event>
                <sub_title>CROHN'S DISEASE</sub_title>
                <counts group_id="E1" events="84" subjects_affected="64" subjects_at_risk="1121"/>
                <counts group_id="E2" events="195" subjects_affected="153" subjects_at_risk="1541"/>
                <counts group_id="E3" events="23" subjects_affected="19" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" events="153" subjects_affected="124" subjects_at_risk="1121"/>
                <counts group_id="E2" events="376" subjects_affected="281" subjects_at_risk="1541"/>
                <counts group_id="E3" events="48" subjects_affected="37" subjects_at_risk="298"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The sponsor shall have editorial rights with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Vice President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp.</organization>
      <phone>1-800-672-6372</phone>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

